Search bioRxiv⌕ Search

Biology subjects

Ottenheijm, R.

Publications and source records attributed to Ottenheijm, R..

2 recordsLinked to original sources

Cytosine base editing workflow for quality-controlled multiplex-knockout hiPSC lines

Dissecting polygenic disease mechanisms requires human cell models that harbour multiple targeted genetic modifications in a defined background. However, generating and rigorously validating such models remains difficult. We developed a cytosine base editing workflow to generate multiplex-knockout (KO) human induced pluripotent stem cell (hiPSC) lines. First, we assessed six cytosine base editor (CBE) variants and selected evoBE4max. We then combined sgRNA-guided introduction of premature termination codons and splice-site mutations with fluorescence-based enrichment. This yielded a median on-target C-to-T editing efficiency of 77.5% (range, 27.0-86.5%) across six loci. We generated single-, double-, and triple-KO hiPSC lines for endolysosomal Ca{superscript 2} signalling components (OCaR2, TPC1, TPC2) and confirmed loss-of-function at transcript and protein levels. We performed extensive quality control, including pluripotency assessment, SNP-array karyotyping, and whole-genome sequencing, which indicated minimal guide-directed off-target editing. We further extended multiplex editing to ORAI Ca{superscript 2} channel paralogs. This framework supports scalable production of quality-controlled multiplex-KO hiPSC lines.

genetics↗

JPT2/HN1L functions as an NAADP-binding protein in a cell type-specific manner

Nicotinic acid adenine dinucleotide phosphate (NAADP) is a second messenger evoking Ca2+ release from intracellular Ca2+ stores by targeting several Ca2+ channels, including two-pore channels (TPC1/2), transient receptor potential mucolipin-1 (TRPML1), or ryanodine receptor type 1 (RYR1). For activation of Ca2+ channels, NAADP requires binding proteins, such as JPT2/HN1L and LSM12. So far, their function has been analyzed in several cell lines and only a very limited number of primary cells; however, their physiological relevance in cell types known to utilize NAADP signaling remains unclear. Here, we generated Jpt2/Hn1l-/- mice to evaluate the contribution of JPT2/HN1L proteins to platelet aggregation and Ca2+ signaling in cardiomyocytes, mast cells, and T cells. NAADP is known to contribute to collagen-related peptide (CRP-XL)- evoked platelet aggregation, but this was not altered by JPT2/HN1L deletion. Functional Ca2+ imaging revealed that JPT2/HN1L plays a strikingly cell-type specific role in NAADP-mediated Ca2+ release. In electrically paced ventricular cardiomyocytes, {beta}-adrenergic stimulation is known to evoke arrhythmogenic spontaneous diastolic Ca2+ transients, which were not altered in their frequency in Jpt2/Hn1l-/- myocytes. Further, antigen-evoked Ca2+ transients in peritoneal mast cells (PMCs) are not changed in Jpt2/Hn1l-/- PMCs. However, CD4+ T cells displayed a pronounced requirement for JPT2/HN1L. Following T cell receptor/CD3 stimulation, global Ca2+ elevations and early NAADP-driven Ca2+ microdomains, which occur within tens of milliseconds of TCR/CD3 engagement and serve as initiating signals for downstream immune activation, were significantly decreased in Jpt2/Hn1l-/- CD4+ cells. We conclude that JPT2/HN1L is indispensable for NAADP-mediated Ca2+ release in T cells, but dispensable in cardiomyocytes, platelets, and mast cells, at least for the agonists employed. Accordingly, LSM12 might compensate for the loss of JPT2/HN1L. Together, JPT2/HN1L is not universally required as an NAADP-binding protein but exhibits cell-type specificity, with an essential function in T cell Ca2+ signaling.

pharmacology and toxicology↗